AI assistant
Sending…
Acumen Pharmaceuticals, Inc. — Director's Dealing 2021
Jul 1, 2021
34208_dirs_2021-06-30_0f62abd2-ff8e-4362-9089-77057b6f5de6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Acumen Pharmaceuticals, Inc. (ABOS)
CIK: 0001576885
Period of Report: 2021-06-30
Reporting Person: Stoppel Laura (Director)
More from Acumen Pharmaceuticals, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 26
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Jan 28
Director's Dealing
2026
Jan 23
Director's Dealing
2026
Jan 23
Director's Dealing
2026
Jan 23